You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.
At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.
Rakuten invests in Japanese genetic testing company Genesis
Corporate Credit Risk Trends in Developing Markets An Expected Credit Loss ECL Perspective
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Q&A: Data That Delivers - Automating the Credit Risk Workflow
Japanese genetic testing company Genesis Healthcare Co. said Feb. 27 that online retailer Rakuten Inc. and Omron Healthcare Co. Ltd. invested in Genesis to bring its valuation to ¥42 billion.
The details of the investment were not disclosed. Genesis said that this was Rakuten's second investment in Genesis. The retailer bought about ¥1.4 billion worth of Genesis shares in August 2017.
As of Feb. 26, US$1 was equivalent to ¥106.92.